Participants will explore cutting-edge therapies in leukemia treatment, including allogeneic transplants’ potential to trigger immune-mediated responses against leukemia. The session will also dive into the complexities of managing and preventing acute and chronic graft-versus-host disease (GVHD) and the challenges they post in patient care.
- Provider:Horizon CME, Inc.
- Activity Link: http://default/node/1487
- Start Date: 2024-04-19 05:00:00
- End Date: 2024-04-19 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest